Palumbo Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$679K Sell
17,844
-11,443
-39% -$482K 0.14% 103
2026
Q2
$1.38M Sell
29,287
-8,679
-23% -$214K 0.29% 60
2026
Q1
$718K Sell
37,966
-1,036
-3% -$17.6K 0.18% 91
2025
Q4
$522K Buy
39,002
+6,073
+18% +$75.2K 0.13% 121
2025
Q3
$388K Buy
32,929
+8,886
+37% +$82.9K 0.12% 113
2025
Q2
$156K Buy
24,043
+1,415
+6% +$9.31K 0.05% 188
2025
Q1
$132K Buy
+22,628
New +$162K 0.04% 176

Other funds holding DFTX

Palumbo Wealth Management's DFTX Position: Q3 2026 in Review

Palumbo Wealth Management reduced its Definium Therapeutics (DFTX) stake by 39% in Q3 2026, selling an estimated $482K and leaving 17,844 shares worth $679K. The position accounts for 0.14% of the portfolio, ranked #103.

Palumbo Wealth Management first reported a position in DFTX in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.38M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Palumbo Wealth Management held 17,844 shares of Definium Therapeutics worth $679K as of Q3 2026.
  • Palumbo Wealth Management sold 11,443 Definium Therapeutics shares in Q3 2026, an estimated $482K.
  • Definium Therapeutics made up 0.14% of Palumbo Wealth Management's portfolio in Q3 2026, its #103 holding.
  • Palumbo Wealth Management first reported a position in Definium Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • Palumbo Wealth Management's Definium Therapeutics position peaked at $1.38M in Q2 2026.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Palumbo Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.